Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4LS
|
||||
Former ID |
DNC008723
|
||||
Drug Name |
Go-Y026
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529286] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H22O7
|
||||
Canonical SMILES |
COC1=CC(=CC(=C1O)OC)C=CC(=O)C=CC2=CC(=C(C(=C2)OC)O)OC
|
||||
InChI |
1S/C21H22O7/c1-25-16-9-13(10-17(26-2)20(16)23)5-7-15(22)8-6-14-11-18(27-3)21(24)19(12-14)28-4/h5-12,23-24H,1-4H3/b7-5+,8-6+
|
||||
InChIKey |
DDGVRFAFSCAHHH-KQQUZDAGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [529286] | |
PathWhiz Pathway | Caffeine Metabolism | ||||
Retinol Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.